Skip to main content
Premium Trial:

Request an Annual Quote

Protogene Laboratories,Rosetta Inpharmatics

Premium

Protogene Laboratories of Menlo Park, Calif., announced plans to market, manufacture, and provide custom oligonucleotide DNA microarrays for academic and commercial genomics research scientists. Researchers will be able to specify what they want on a chip and the company will supply them with the finished product within days, said Christopher Wolf, president and CEO of Protogene.

Rosetta Inpharmatics has released version 1.6 of its Rosetta Resolver Expression Data Analysis System. This is the latest release of Rosetta Inpharmatics’ enterprise-wide bioinformatics solution for large-scale gene expression analysis. Enhancements to the system include the addition of several new clustering algorithms and the disclosure of elements of the system’s Application Program Interface. All Rosetta Resolver system customers with an existing support contract will be upgraded to the new version of the product at no additional cost.

Filed under

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.